Quantitative Systematic Strategies’s Integra LifeSciences IART Stock Holding History

Quantitative Systematic Strategies’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,115	Closed	-$337K	–	766
2018 Q3	$337K	Sell	5,115 -11	-0.2%	-$684	0.06%	389
2018 Q2	$330K	Buy	5,126 +255	+5%	+$15.8K	0.06%	444
2018 Q1	$270K	Buy	+4,871	New	+$255K	0.06%	482
2017 Q4	–	Sell	-5,231	Closed	-$264K	–	598
2017 Q3	$264K	Buy	+5,231	New	+$269K	0.07%	353
2017 Q1	–	Sell	-24,480	Closed	-$1.05M	–	387
2016 Q4	$1.05M	Sell	24,480 -1,826	-7%	-$74.2K	0.43%	102
2016 Q3	$1.09M	Buy	26,306 +15,998	+155%	+$670K	0.4%	95
2016 Q2	$402K	Buy	+10,308	New	+$371K	0.19%	191
2016 Q1	–	Sell	-20,656	Closed	-$706K	–	581
2015 Q4	$706K	Buy	20,656 +6,346	+44%	+$198K	0.19%	110
2015 Q3	$426K	Buy	+14,310	New	+$447K	0.21%	178

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantitative Systematic Strategies's IART Position: Q4 2018 in Review

Quantitative Systematic Strategies sold out of Integra LifeSciences (IART) in Q4 2018, closing a stake of 5,115 shares — an estimated $337K sold.

Quantitative Systematic Strategies first reported a position in IART in Q3 2015 and held it in 9 quarters. The position peaked at $1.09M in Q3 2016. 248 funds tracked by Wall St. Rank hold IART as of Q4 2018.

Quantitative Systematic Strategies reported no remaining Integra LifeSciences position as of Q4 2018 after selling out during the quarter.
Quantitative Systematic Strategies sold 5,115 Integra LifeSciences shares in Q4 2018, an estimated $337K.
Quantitative Systematic Strategies first reported a position in Integra LifeSciences in Q3 2015 and held it in 9 quarters.
Quantitative Systematic Strategies's Integra LifeSciences position peaked at $1.09M in Q3 2016.
248 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2018, filed 12 Feb 2019.